A.R.T. Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,850
Closed -$47K 1797
2019
Q3
$47K Sell
1,850
-974
-34% -$24.7K ﹤0.01% 1324
2019
Q2
$72K Buy
2,824
+715
+34% +$18.2K ﹤0.01% 1227
2019
Q1
$90K Buy
+2,109
New +$90K 0.01% 1183